Literature DB >> 9688100

School-based adolescent hepatitis B immunization programs in the United States: strategies and successes.

W Cassidy1.   

Abstract

BACKGROUND: To increase hepatitis B vaccination coverage of adolescents, a public/private partnership was organized in the greater Baton Rouge area of Louisiana in 1992 to fund and implement school-based vaccination programs.
METHODS: Initial programs utilized schools with existing school-based clinics and administered 2 to 3 doses of hepatitis B vaccine to up to 76% of eligible students. During 1996 to 1997, expansion from 4 schools to 68 schools was facilitated by the use of temporary clinics set up in open school space. This multifaceted program administered 3 doses of hepatitis B vaccine to 3232 students (75%) and 2 doses to 171 students (4%). Administration of the 3-dose regimen of hepatitis B vaccine was aided by the use of a dosing schedule at 0, 2 and 4 months. This accelerated dosing has been shown to provide seroprotection for greater than 95% of healthy adolescents.
RESULTS: In the Baton Rouge area, the hepatitis B adolescent vaccination program has immunized approximately 5000 adolescents during a 5-year period with minimal use of financial and personnel resources.
CONCLUSIONS: The success and growth of this program demonstrate that school-based vaccination programs can be highly efficient and effective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688100     DOI: 10.1097/00006454-199807001-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  A middle school immunization law rapidly and substantially increases immunization coverage among adolescents.

Authors:  Francisco Averhoff; Leslie Linton; K Michael Peddecord; Christine Edwards; Wendy Wang; Daniel Fishbein
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

2.  School-based HPV immunization of young adolescents: effects of two brief health interventions.

Authors:  Vaughn I Rickert; Beth A Auslander; Dena S Cox; Susan L Rosenthal; Richard E Rupp; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.